We are happy to be

serving you directly

Read our IVDR Update


Genetics and Oncology Diagnostics for the EMEA Market

Regulations can vary significantly between countries and markets, so it’s crucial for companies to stay up to date with the latest requirements and ensure their products comply accordingly. As a Bio-Techne brand, Asuragen is an established and trusted authority in the EMEA region, with a deep understanding of the nuanced regulatory landscape. By leveraging this expertise, Asuragen provides tailored solutions that meet the specific and ever-changing requirements of the EMEA market, ensuring compliance with relevant regulations and standards.


The AmplideX® genetics and QuantideX® oncology solutions are optimized with kitted reagents and time-saving analysis software to provide accurate results, while simplifying workflows. Asuragen’s value extends beyond the lab to include personalized customer service, exclusive educational resources, and a true partnership approach.

Learn more about Asuragen’s portfolio of genetics and oncology testing solutions.

Genetics Portfolio
Oncology Portfolio

Contact Us:

Back To